Valeur pronostique des taux sériques de cholestérol et de l'apolipoprotéine A1 dans le cancer pulmonaire

Annales de Biologie Clinique

Volumn 55, Issue 1, 1997, Pages 52-

  Charet, J C ^a   Watine, J ^a   Marre, A ^a   Charet, P ^b  

^a HÔPITAL DU BOCAGE   (France)

^b IUT A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL;

BLOOD; BRONCHUS TUMOR; HUMAN; LETTER; LUNG TUMOR; PROGNOSIS; PROSPECTIVE STUDY;

APOLIPOPROTEIN A-I; BRONCHIAL NEOPLASMS; CHOLESTEROL; HUMANS; LUNG NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0345308249     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Adnaoui M, Dellinger A, Vital-Durand D, Bienvenu J, Sibille M, Levrat R. Changes in plasma apolipoproteins Al and B during inflammatory response. Ear J Intern Med 1991 ;2: 101-5.
2. Dessi S, Batetta B, Pulisci D, Accogli P, Pani P, Broccia G. Total and HDL cholesterol in human hematologie neoplasms. Int J Hemalol 1991 ; 54: 483-6.
3. Jacobs D, Blackburn H, Higgins M, et al. Report of the Conference on low blood cholesterol : mortality associations. Circulation 1992 ; 86 : 1046-60.
4. Charet JC, Watine J, Leprêtre A, Raimbault C, Charet P. Orosomucoïd : prealbumin ratio in the monitoring of lung cancer. Clinical Biochemistry 1996 ; 29 : 287-90.
5. Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Enr Resp 71994;?: 1350-64.